0169-2662Level 3
Tresiba (insulin degludec)
**Product type:** Human Prescription Drug
**Active ingredient:** INSULIN DEGLUDEC
**Strength:** 100 U/mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Novo Nordisk
**Marketing category:** BLA (BLA203314)
**Pharmacologic class:** Insulin Analog [EPC], Insulin [CS]
GET
/api/v1/systems/ndc_fda/nodes/0169-2662Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.